Theoretical and Natural Science

- The Open Access Proceedings Series for Conferences


Theoretical and Natural Science

Vol. 21, 20 December 2023


Open Access | Article

Research on the parasomnia’s classifications, symptoms and treatments

Linhan Zhong * 1
1 Shenyang New Channel Xiangyu Middle School A Level Center

* Author to whom correspondence should be addressed.

Theoretical and Natural Science, Vol. 21, 64-69
Published 20 December 2023. © 2023 The Author(s). Published by EWA Publishing
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citation Linhan Zhong. Research on the parasomnia’s classifications, symptoms and treatments. TNS (2023) Vol. 21: 64-69. DOI: 10.54254/2753-8818/21/20230819.

Abstract

Parasomnia is a neurological disorder that refers to abnormal behavior during sleep. This disease has received increasing attention and research over the past few decades. In the 1950s, the symptoms of parasomnia were first described and further studied. This paper describes the three classifications of parasomnias, and details the symptoms and treatment options for these three classifications. By reading and analyzing the previous literature, it can be concluded that the types of parasomnia can be roughly divided into circadian dysrhythmia sleep disorder, sleep apnea syndrome, and restless leg syndrome. Circadian dysrhythmia sleep disorder is characterized by late sleep, insufficient or excessive sleep duration, resulting in daytime fatigue, a lack of concentration, and other symptoms. The treatment method is light therapy. The main symptom of sleep apnea is that breathing stops during sleep, resulting in a lack of oxygen supply. The treatment is to improve the maxillofacial structure through surgery to reduce the problem of dyspnea. The most obvious symptom of restless leg syndrome is discomfort and unbearable numbness in the lower legs and feet while sleeping. There are three ways to treat this condition. A more non-pharmacological treatment is to do some exercise to reduce the discomfort of the leg muscles, a medical treatment is to give the patient levodopa, and if the syndrome is caused by a lack of iron in the body, iron supplementation is sufficient.

Keywords

clock gene, circadian dysrhythmia, restless leg syndrome, levodopa, sleep apnea syndrome.

References

1. Takahashi, J. S. , Hong, H. K. , Ko, C. H. , & Mcdearmon, E. L. . (2008). Takahashi js, hong h-k, ko ch, mcdearmon el. the genetics of mammalian circadian order and disorder: implications for physiology and disease. nat rev genet 9: 764-775. Nature Reviews Genetics, 9(10), 764-775.

2. Jiajun, Shi, Jacqueline, K., Wittke-Thompson, & Judith, et al. (2008). Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B(7), 1047-1055.

3. Katsuhisa Banno; Meir H. Kryger(2007). Sleep apnea: Clinical investigations in humans. , 8(4), 0-426

4. Kryger MH. Diagnosis and management of sleep apnea syndrome. Clin Cornerstone 2000;2(5):39–47

5. Kryger MH. Pathophysiology of obstructive sleep apnea syndrome. In: Fabiani M, editor. Surgery for snoring and obstructive sleep apnea syndrome. The Hague, The Netherlands: Kugler Publications; 2003. p. 47–61

6. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleepdisordered breathing. JAMA 2000;284(23):3015–21

7. Redline S, Kump K, Tishler PV, Browner I, Ferrette V. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med 1994;149:722–6.

8. Cistulli PA, Grunstein RR, Sullivan CE. Effect of testosterone administration on upper airway collapsibility during sleep. Am J Respir Crit Care Med 1994;149(2, Pt. 1):530–2.

9. Ekbom KA. Restless legs. Acta Med Scand 1945; 158: 1–123.

10. Ekbom KA. Restless legs syndrome. Neurology 1960; 10: 868–73.

11. Ulfberg J, Nystro¨m B, Carter N, Edling C. Restless legs syndrome among working-aged women. Eur Neurol 2001; 46: 17–9

12. Ferri R. The time structure of leg movement activity during sleep: the theory behind the practice. Sleep Med 2012;13:433–441.

13. Ondo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology 2000; 55:1404–6.

14. Ekbom KA. Restless legs. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam: North-Holland Publ Company 1970; 8: 311–20.

15. Gooley JJ. Treatment of circadian rhythm sleep disorders with light. Ann Acad Med Singap. 2008 Aug;37(8):669-76.

16. Olsen, Kerry D; Suh, Ku W ; Staats, Bruce A.(1981). Surgically Correctable Causes of Sleep Apnea Syndrome. Otolaryngology-Head and Neck Surgery, 89(5),726-731.

17. Youngstedt, Shawn D. (2005). Effects of Exercise on Sleep. , 24(2), 355–365.

18. Conti CF, de Oliveira MM, Andriolo RB, Saconato H, Atallah AN, Valbuza JS, et al. Levodopa for idiopathic restless legs syndrome: evidence-based review. Mov Disord 2007;22:1943–1951.

19. Comella, Cynthia L. (2014). Treatment of Restless Legs Syndrome. Neurotherapeutics, 11(1), 177–187.

20. Cho YW, Allen RP, Earley CJ. Lower molecular weight intravenous iron dextran for restless legs syndrome. Sleep Med 2013;14:274–277. 31.

21. Earley CJ. The importance of oral iron therapy in restless legs syndrome. Sleep Med 2009;10:945–946

22. Comella CL. Treatment of restless legs syndrome. Neurotherapeutics. 2014 Jan;11(1):177-87. doi: 10.1007/s13311-013-0247-9. PMID: 24363103; PMCID: PMC3899490.

Data Availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:

1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).

Volume Title
Proceedings of the 3rd International Conference on Biological Engineering and Medical Science
ISBN (Print)
978-1-83558-215-2
ISBN (Online)
978-1-83558-216-9
Published Date
20 December 2023
Series
Theoretical and Natural Science
ISSN (Print)
2753-8818
ISSN (Online)
2753-8826
DOI
10.54254/2753-8818/21/20230819
Copyright
20 December 2023
Open Access
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Copyright © 2023 EWA Publishing. Unless Otherwise Stated